Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lucarini

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|July 19, 2023
Editorial: The challenges of drug repurposing in diseases related to chronic inflammationDebora Collotta, Laura Lucarini
Biomolecules|May 28, 2022
New Insight in Histamine FunctionsSilvia Sgambellone, Silvia Marri, Emanuela Masini, et al.
Biomolecules|August 27, 2021
Novel Insight of Histamine and Its Receptor Ligands in Glaucoma and Retina NeuroprotectionSilvia Sgambellone, Laura Lucarini, Cecilia Lanzi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 17, 2020
Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple SclerosisVittoria Borgonetti, Maria Domenica Sanna, Laura Lucarini, et al.
Journal of Cellular and Molecular Medicine|January 22, 2014
Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodellingLaura Lucarini, Alessandro Pini, Elisabetta Gerace, et al.
British Journal of Pharmacology|October 8, 2016
Histamine H<sub>4</sub> receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stressMaria Domenica Sanna, Laura Lucarini, Mariaconcetta Durante, et al.
Pain|August 14, 2015
Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylationMaria D Sanna, Holger Stark, Laura Lucarini, et al.
Frontiers in Pharmacology|November 14, 2018
A Selective Histamine H<sub>4</sub> Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral IschemiaIlaria Dettori, Lisa Gaviano, Alessia Melani, et al.
Bioorganic & Medicinal Chemistry|July 22, 2017
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leadsMarta Ferraroni, Laura Lucarini, Emanuela Masini, et al.
Frontiers in Pharmacology|June 6, 2019
Effects of PARP-1 Deficiency and Histamine H<sub>4</sub> Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in MiceMariaconcetta Durante, Silvia Sgambellone, Cecilia Lanzi, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|July 19, 2023
Editorial: The challenges of drug repurposing in diseases related to chronic inflammationDebora Collotta, Laura Lucarini
Biomolecules|May 28, 2022
New Insight in Histamine FunctionsSilvia Sgambellone, Silvia Marri, Emanuela Masini, et al.
Biomolecules|August 27, 2021
Novel Insight of Histamine and Its Receptor Ligands in Glaucoma and Retina NeuroprotectionSilvia Sgambellone, Laura Lucarini, Cecilia Lanzi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 17, 2020
Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple SclerosisVittoria Borgonetti, Maria Domenica Sanna, Laura Lucarini, et al.
Journal of Cellular and Molecular Medicine|January 22, 2014
Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodellingLaura Lucarini, Alessandro Pini, Elisabetta Gerace, et al.
British Journal of Pharmacology|October 8, 2016
Histamine H<sub>4</sub> receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stressMaria Domenica Sanna, Laura Lucarini, Mariaconcetta Durante, et al.
Pain|August 14, 2015
Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylationMaria D Sanna, Holger Stark, Laura Lucarini, et al.
Frontiers in Pharmacology|November 14, 2018
A Selective Histamine H<sub>4</sub> Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral IschemiaIlaria Dettori, Lisa Gaviano, Alessia Melani, et al.
Bioorganic & Medicinal Chemistry|July 22, 2017
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leadsMarta Ferraroni, Laura Lucarini, Emanuela Masini, et al.
Frontiers in Pharmacology|June 6, 2019
Effects of PARP-1 Deficiency and Histamine H<sub>4</sub> Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in MiceMariaconcetta Durante, Silvia Sgambellone, Cecilia Lanzi, et al.
Pageof 6